No abstract

No abstract

A series of ternary OPVs are fabricated with one wide bandgap polymer D18-Cl as donor, well compatible Y6 and Y6-1O as acceptor. The open-circuit-voltage (VOC) of ternary OPVs is monotonously increased along with the incorporation of Y6-1O, indicates that the alloy state should be formed between Y6 and Y6-1O due to their excellent compatibility. The energy loss can be minimized by incorporating Y6-1O, leading to the VOC improvement of ternary OPVs. By finely adjusting the Y6-1O content, the PCE of 17.91% is achieved in the optimal ternary OPVs with 30 wt% Y6-1O in acceptors, resulting from synchronously improved short-circuit-current density (JSC) of 25.87 mA cm−2, fill factor (FF) of 76.92%, and VOC of 0.900 V in comparison with those of D18-Cl:Y6 binary OPVs. The JSC and FF improvement of ternary OPVs should be ascribed to comprehensively optimal photon harvesting, exciton dissociation and charge transport in ternary active layers. The more efficient charge separation and transport process in ternary active layers can be confirmed from the magneto-photocurrent and impedance spectroscopy experimental results, respectively. This work provides new sight on constructing highly efficient ternary OPVs with well compatible Y6 and its derivative as acceptor.

Increasing evidence indicates that the secretome of mesenchymal stem cells (MSCs) has therapeutic potential for the treatment of various diseases, including cartilage disorders. However, the paracrine mechanisms underlying cartilage repair by MSCs are poorly understood. Here, we show that human umbilical cord blood-derived MSCs (hUCB-MSCs) promoted differentiation of chondroprogenitor cells by paracrine action. This paracrine effect of hUCB-MSCs on chondroprogenitor cells was increased by treatment with synovial fluid (SF) obtained from osteoarthritis (OA) patients but was decreased by SF of fracture patients, compared to that of an untreated group. To identify paracrine factors underlying the chondrogenic effect of hUCB-MSCs, the secretomes of hUCB-MSCs stimulated by OA SF or fracture SF were analyzed using a biotin label-based antibody array. Among the proteins increased in response to these two kinds of SF, thrombospondin-2 (TSP-2) was specifically increased in only OA SF-treated hUCB-MSCs. In order to determine the role of TSP-2, exogenous TSP-2 was added to a micromass culture of chondroprogenitor cells. We found that TSP-2 had chondrogenic effects on chondroprogenitor cells via PKCa, ERK, p38/MAPK, and Notch signaling pathways. Knockdown of TSP-2 expression on hUCB-MSCs using small interfering RNA abolished the chondrogenic effects of hUCB-MSCs on chondroprogenitor cells. In parallel with in vitro analysis, the cartilage regenerating effect of hUCB-MSCs and TSP-2 was also demonstrated using a rabbit full-thickness osteochondral-defect model. Our findings suggested that hUCB-MSCs can stimulate the differentiation of locally presented endogenous chondroprogenitor cells by TSP-2, which finally leads to cartilage regeneration.

Although the rapid development of polymer solar cells (PSCs) has been achieved, it is still a great challenge to explore efficient ways for improving power conversion efficiency (PCE) of PSCs from materials and device engineering. Ternary strategy has been confirmed as an efficient way to improve PCE of PSCs by employing three kinds of materials. In this work, one polymer donor PM6, and two non‐fullerene materials N3 and MF1 are selected to prepare ternary PSCs with layer‐by‐layer (LbL) or bulk‐heterojunction (BHJ) structure. The LbL and BHJ‐PSCs exhibit PCEs of 16.75% and 16.76% with 15 wt% MF1 content in acceptors, corresponding to over 5% or 4% PCE improvement compared with N3‐based binary PSCs with LbL or BHJ structure. The PCE improvement is mainly attributed to the fill factor enhancement from 73.29% to 76.95% for LbL‐PSCs or from 74.13% to 77.51% for BHJ‐PSCs by employing the ternary strategy. This work indicates that ternary strategy has great potential in preparing highly efficient LbL‐PSCs via simultaneously optimizing molecular arrangement and the thickness of each layer.

Mesenchymal stem cells (MSCs) are of particular interest for the treatment of immune-related diseases due to their immunosuppressive capacity. Here, we show that Small MSCs primed with Hypoxia and Calcium ions (SHC-MSCs) exhibit enhanced stemness and immunomodulatory functions for treating allogeneic conflicts. Compared with naïve cultured human umbilical cord blood-derived MSCs, SHC-MSCs were resistant to passage-dependent senescence mediated via the monocyte chemoattractant protein-1 and p53/p21 cascade and secreted large amounts of pro-angiogenic and immunomodulatory factors, resulting in suppression of T-cell proliferation. SHC-MSCs showed DNA demethylation in pluripotency, germline, and imprinted genes similarly to very small embryonic-like stem cells, suggesting a potential mutual relationship. Genome-wide DNA methylome and transcriptome analyses indicated that genes related to immune modulation, cell adhesion, and the cell cycle were up-regulated in SHC-MSCs. Particularly, polo-like kinase-1 (PLK1), zinc-finger protein-143, dehydrogenase/reductase-3, and friend-of-GATA2 play a key role in the beneficial effects of SHC-MSCs. Administration of SHC-MSCs or PLK1-overexpressing MSCs significantly ameliorated symptoms of graft-versus-host disease (GVHD) in a humanized mouse model, resulting in significantly improved survival, less weight loss, and reduced histopathologic injuries in GVHD target organs compared with naïve MSC-infused mice. Collectively, our findings suggest that SHC-MSCs can improve the clinical treatment of allogeneic conflicts, including GVHD.

No abstract

No abstract